Telehealth Services for Mental Health Care: A Secret Shopper Study

By Staff Writer

February 22, 2024

Introduction:

There have been major shifts in healthcare delivery due to the recent pandemic, with telehealth being one area that has seen the most impact. In the United States, the use of telehealth services for mental health care has seen a remarkable increase, fuelled by changes in federal and state policies related to financial reimbursement of these services.

The Rise of Telehealth in Mental Health Care:

Particularly in the midst of the epidemic, telehealth has emerged as an indispensable instrument for the delivery of mental health treatments. According to studies, the overall volume of services for mental health issues has remained consistent, despite constraints on in-person care. This can be partly due to the rise in the number of telehealth appointments. On the other hand, the availability of these telehealth services and the makeup of these services are still substantially unexplored.

The Secret Shopper Approach:

A ‘Secret Shopper’ strategy was utilised in a recent study in order to gain an understanding of the present landscape of telehealth services for mental health care professionals. In this approach, researchers make contact with establishments while posing as potential customers in order to inquire about the availability of services. By taking this method, a clear and up-to-date image of the layout of services across the United States is provided.

Findings and Discussions:

The survey revealed that approximately one in five facilities did not respond despite multiple attempts. Among those successfully contacted, most were accepting new clients and offering telehealth services. However, the availability of telehealth services varied across states, and there was heterogeneity in the types of clinical services offered via telehealth.

Figure 1. State-Specific Median Wait Times to Next Available Telehealth Appointment
at Surveyed Mental Health Treatment Facilities

The survey also found that the median wait time for a telehealth appointment was over two weeks, with significant geographic variation. Interestingly, private facilities were nearly twice as likely to offer telehealth services compared with public facilities.

Implications and Future Directions:

These findings underscore potential heterogeneity in the availability of treatment from specialty practitioners in the US. More work is needed to investigate the possible reasons for these differences. Policymakers should consider broadening policies allowing facilities to offer telehealth across state lines to improve telehealth wait times.

Figure 2. State-Specific Proportions of Surveyed Mental Health Treatment Facilities
With Reported Telehealth Services

Conclusion:

The COVID-19 pandemic has undeniably accelerated the shift towards telehealth in mental health care. However, prospective clients may face several hurdles in finding a facility that offers comprehensive telehealth services. Therefore, it is paramount to continue exploring ways to optimise the availability and accessibility of these services.

Reference url

Recent Posts

Navigating Challenges for Small Countries to Access Innovative Medicines

By João L. Carapinha

July 31, 2025

Access to innovative medicines is a pressing issue for patients in smaller European countries. These nations often face significant barriers in obtaining timely and equitable healthcare solutions. The article "Ensuring access to innovative medicines for patients in smaller countries" (linked belo...
Mental Health Policy Integration: A Cross-Sector Imperative for Well-being and Productivity
The purpose of this update is to review a recent Lancet editorial (linked below) on mental health policy integration in public policy frameworks. The article “Mental health in all policies” emphasizes that mental health influences individual well-being, societal cohesion, and economic productivit...
Novartis Gains Approval for Groundbreaking Malaria Treatment for Infants

By Rene Pretorius

July 30, 2025

In this article we review Swissmedic's approval of Novartis' Coartem Baby. It is the first malaria treatment for infants under 4.5 kilograms. This novel formulation addresses a critical gap in antimalarial care. Existing treatments were unsuitable due to dosing and metabolism concerns in young in...